FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

871530006: Passive immunity stimulant therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2020. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3973199017 Passive immunity stimulant therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module
3973200019 Passive immunity stimulant therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Passive immunity stimulant therapeutic role Is a Therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Medicinal product acting as passive immunity stimulant (product) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing Varicella-zoster virus antibody (medicinal product) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Varicella immunoglobulin Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely Varicella-zoster virus antibody 104 unit/1 milliliter conventional release solution for injection (clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing Varicella-zoster virus antibody in parenteral dose form (medicinal product form) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing only Varicella-zoster virus antibody in parenteral dose form (medicinal product form) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely Varicella-zoster virus antibody 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely Varicella-zoster virus antibody 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing palivizumab Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Palivizumab Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing only palivizumab in parenteral dose form (medicinal product form) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely palivizumab 50 milligram/1 vial powder for conventional release solution for injection Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing palivizumab in parenteral dose form (medicinal product form) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing human tetanus immunoglobulin (medicinal product) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Tetanus immunoglobulin Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing human tetanus immunoglobulin in parenteral dose form (medicinal product form) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing only human tetanus immunoglobulin in parenteral dose form (medicinal product form) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing Hepatitis B surface antigen immunoglobulin (medicinal product) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Hepatitis B immunoglobulin Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely Hepatitis B surface antigen immunoglobulin 312 unit/1 milliliter conventional release solution for injection (clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing Hepatitis B surface antigen immunoglobulin in parenteral dose form (medicinal product form) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing only Hepatitis B surface antigen immunoglobulin in parenteral dose form (medicinal product form) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing rabies human immune globulin Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Rabies immunoglobulin Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing rabies human immune globulin in parenteral dose form (medicinal product form) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely rabies human immune globulin 150 unit/1 milliliter conventional release solution for injection (clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing only rabies human immune globulin in parenteral dose form (medicinal product form) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing equine diphtheria antitoxin (medicinal product) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing equine diphtheria antitoxin in parenteral dose form (medicinal product form) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing only equine diphtheria antitoxin in parenteral dose form (medicinal product form) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing only equine diphtheria antitoxin (medicinal product) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing Cytomegalovirus antibody in parenteral dose form (medicinal product form) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing only Cytomegalovirus antibody in parenteral dose form (medicinal product form) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing Cytomegalovirus antibody (medicinal product) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Cytomegalovirus immunoglobulin Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely human tetanus immunoglobulin 250 international unit/1 milliliter conventional release solution for injection (clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely palivizumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely Hepatitis B surface antigen immunoglobulin 500 unit/1 milliliter conventional release solution for injection (clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely Hepatitis B surface antigen immunoglobulin 50 unit/1 milliliter conventional release solution for injection (clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely human tetanus immunoglobulin 100 international unit/1 milliliter conventional release solution for injection (clinical drug) Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Tetanus immunoglobulin human 250unit solution for injection vials Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Hepatitis B immunoglobulin human 500unit solution for injection vials Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Hepatitis B immunoglobulin human 200unit solution for injection vials Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Tetanus immunoglobulin 250units/1ml solution for injection pre-filled syringes Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Palivizumab 50mg/0.5ml solution for injection vials Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Palivizumab 50mg powder and solvent for solution for injection vials Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Cytomegalovirus immunoglobulin human 5,000units/50ml solution for infusion vials Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Hepatitis B immunoglobulin human 500unit solution for injection vials Plays role False Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Palivizumab 100mg powder and solvent for solution for injection vials Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Cytomegalovirus immunoglobulin human 1000units/10ml solution for infusion vials Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Hepatitis B immunoglobulin human 5000units/100ml solution for injection vials Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Hepatitis B immunoglobulin human 2000units/40ml solution for infusion vials Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Palivizumab 100mg/1ml solution for injection vials Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Hepatitis B immunoglobulin human 200unit solution for injection vials Plays role False Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Hepatitis B immunoglobulin human 500unit solution for injection pre-filled syringes Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Cytomegalovirus immunoglobulin human 3g powder for solution for injection vials Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Hepatitis B immunoglobulin human 100units/2ml solution for infusion vials Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Hepatitis B immunoglobulin human 500units/10ml solution for infusion vials Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier
Rabies immunoglobulin human 500unit solution for injection vials Plays role True Passive immunity stimulant therapeutic role Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start